Integrated Buprenorphine Treatment: E2i Toolkit

Please note: The content of this website is frozen as of 6/30/2025 and logins are disabled. UCSF has chosen to keep the site’s resources available until HAB announces the results of the new cooperative agreement competition. We will be monitoring the site for security issues but will not be available to add or remove any content or to respond to questions.

June 22, 2022

Buprenorphine Treatment for Opioid Use Disorder in HIV Primary Care (integrated buprenorphine treatment) is an evidence-informed intervention to safely reduce opioid use disorder and improve HIV health outcomes among people with HIV. In collaboration with HIV experts and community members, E2i adapted integrated buprenorphine treatment for the Ryan White HIV/AIDS Program (RWHAP) and produced a toolkit that provides the resources needed to implement integrated buprenorphine treatment within RWHAP settings and other HIV care organizations. Algunos recursos están disponibles en español.

Replication Resources

Buprenorphine E2i Implementation Guide

cover image of manual with title and smiling man

This Guide includes:

How to plan and implement the intervention
Lessons learned during implementation in RWHAP settings
Outcomes from the E2i initiative

Buprenorphine E2i Implementation Guide (PDF)

Buprenorphine E2i: Guía de implementación (PDF)

Buprenorphine Site Video: Consejo de Salud de Puerto Rico Med Centro - Ponce, Puerto Rico

Buprenorphine Site Video: Greater Lawrence Family Health Center Mobile Health Unit - Lawrence, Massachusetts

Buprenorpine Demonstration Video / Vídeo de demostración

This instructional dramatization of how to deliver integrated buprenorphine treatment to clients with HIV and opioid use disorder. Los subtítulos en español están disponibles.